Characteristic | Value |
---|---|
Mean (median) age (years) | 66.52 (68) |
Mean (median) tumour diameter (mm) | 40.56 (32) |
Number of tumours per patient (% of total 75 cases) | |
1 | 57 (76%) |
2 | 4 (10.67%) |
> 2 | 3 (13.33%) |
Sex Male:Female ratio of total 75 cases (% Male) | 38:37 (50.67%) |
Equivocal or suspicious for malignancy on MRI (%) | 11.1% |
Signal on T2 (mean/median(range)) | 1.03/0.96 (0.67–1.54) |
Micro Fat detected (%) | 37.5 |
Median enhancement ratio- Corticomedullary phase (%) | |
Clear cell RCC | 206 |
Papillary RCC | 32 |
Chromophobe RCC | 110 |
Malignancy on final histopathology (% total) | 70.9% |
Clear cell RCC | 35 (48.6%) |
Papillary RCC | 11 (15.3%) |
Chromophobe RCC | 5 (6.9%) |
Benign on final histopathology (%) | 29.1% |
AML | 10 (13.9%) |
Oncocytoma | 11 (15.3%) |